Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study
Published Online: 2023-09-?
Journal: The Lancet OncologyLoading...
Authors: Aditya Bardia•Aleksandr Vasiliev•Cloris Xue•David Chan•Denise A Yardley•Erika Ferreira•Gonzalo Spera•Heather M Moore•Hryhoriy Adamchuk•Isabel Blancas•José Luis Alonso-Romero•Jutta Steinseifer•Marcelo Salgado•Oleksandr Berzoy•Pablo Diego Pérez-Moreno•Peter A Fasching•Pilar Zamora-Auñón•Sara A Hurvitz•Tanja Badovinac Crnjevic•Tharu M Fernando•Vanesa López-Valverde•Vanesa Quiroga•Yeon Hee Park
